In This Article:
LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Curis Inc. (CRIS) on Monday reported a loss of $9.6 million in its fourth quarter.
On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of $1.25.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.36 per share.
The drug developer posted revenue of $3.3 million in the period.
For the year, the company reported a loss of $43.4 million, or $6.88 per share. Revenue was reported as $10.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRIS at https://www.zacks.com/ap/CRIS